Good quality of life in former Buruli ulcer patients with small lesions: long-term follow-up of the BURULICO trial.

ABSTRACT:

Background

Buruli Ulcer is a tropical skin disease caused by Mycobacterium ulcerans, which, due to scarring and contractures can lead to stigma and functional limitations. However, recent advances in treatment, combined with increased public health efforts have the potential to significantly improve disease outcome.

Objectives

To study the Quality of Life (QoL) of former Buruli Ulcer patients who, in the context of a randomized controlled trial, reported early with small lesions (cross-sectional diameter <10 cm), and received a full course of antibiotic treatment.

Methods

127 Participants of the BURULICO drug trial in Ghana were revisited. All former patients aged 16 or older completed the Dermatology Life Quality Index (DLQI) and the abbreviated World Health Organiza

SUBMITTER: Klis S 

PROVIDER: S-EPMC4091870 | biostudies-literature | 2014 Jul

REPOSITORIES: biostudies-literature